Research Article
Topological Descriptors and QSPR Modelling of HIV/AIDS Disease Treatment Drugs
Table 18
Comparison of Molar refractivity.
| Name of drug | Molar refractivity of drug | Molar refractivity computed from regression model | ABC | R | S | GA | M1 | M2 | F | H | HM |
| Vidaza | 51.1 ± 5.0 cm3 | 129.4744 | 131.5672 | 128.2195 | 127.0814 | 131.417 | 136.69 | 142.11 | 129.493 | 139.18 | Lamivudine | | 102.61 | 107.308 | 104.8882 | 102.9254 | 99.281 | 97.148 | 103.71 | 108.2263 | 100.182 | Darunavir | | 351.8619 | 353.3656 | 349.7263 | 345.71 | 353.691 | 357.66 | 365.79 | 349.1477 | 362.101 | Disovey | | 116.4869 | 119.1488 | 116.4133 | 114.7652 | 115.349 | 115.756 | 122.91 | 118.5559 | 119.154 | Maraviroc | | 422.3142 | 411.1256 | 422.2501 | 431.4467 | 436.709 | 450.7 | 433.95 | 415.0744 | 441.678 | Tenofovir | 342.5 ± 3.0 cm3 | 368.0517 | 375.0256 | 369.4033 | 358.7746 | 351.013 | 332.074 | 343.71 | 371.6296 | 338.386 | Tipranavir | 384.6 ± 3.0 cm3 | 478.0001 | 472.0624 | 478.7512 | 476.3564 | 495.625 | 508.85 | 522.27 | 470.064 | 516.512 | Atazanavir | | 587.2368 | 592.7808 | 583.8826 | 579.5126 | 575.965 | 560.022 | 566.43 | 588.5499 | 563.942 | Lopinavir | 512.7 ± 3.0 cm3 | 511.9809 | 526.3568 | 525.6949 | 527.1179 | 495.625 | 485.59 | 453.15 | 535.687 | 468.028 | Abacavir | 338.4 ± 3.0 cm3 | 199.9267 | 195.1032 | 203.2732 | 212.0696 | 211.757 | 225.078 | 211.23 | 201.496 | 217.176 | Etravirine | 339.3 ± 3.0 cm3 | 259.8824 | 255.4624 | 255.8389 | 257.7958 | 259.961 | 259.968 | 259.23 | 254.0551 | 259.336 | Nelfinavir | 429.7 ± 3.0 cm3 | 469.1046 | 456.756 | 457.9498 | 462.6113 | 479.557 | 485.59 | 497.31 | 453.0507 | 492.27 | Toreforant | 323 ± 3.0 cm3 | 376.7693 | 380.224 | 377.2741 | 375.922 | 367.081 | 357.66 | 357.15 | 380.7439 | 357.358 |
|
|